Sonic Healthcare (OTCMKTS:SKHHY – Get Free Report) was downgraded by research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Wednesday,Zacks.com reports.
Sonic Healthcare Stock Down 1.6%
Shares of SKHHY opened at $14.34 on Wednesday. Sonic Healthcare has a fifty-two week low of $12.94 and a fifty-two week high of $19.25. The company has a quick ratio of 0.90, a current ratio of 1.01 and a debt-to-equity ratio of 0.59. The firm’s 50 day moving average price is $14.11 and its 200 day moving average price is $14.72.
Sonic Healthcare Company Profile
Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.
Featured Stories
- Five stocks we like better than Sonic Healthcare
- Microsoft Earnings Are Coming—But Azure and CapEx Will Decide the Reaction
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
